See also this year's filing and all EDGAR filings for this company.
PDF Report 0001729427_2026_CNS_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001729427, CNS Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 8,102,801 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 17,703 |
| 3 | remainder_Assets | 502,962 |
| 4 | LiabilitiesCurrent | 4,100,910 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,214,619 |
| 9 | ResearchAndDevelopmentExpense | 9,771,940 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 135,995 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,623,466 |
| 1 | Liabilities | 4,100,910 |
| 2 | Expenses | 15,986,559 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 4,522,556 |
| 5 | NetIncome | -15,850,564 |
| 6 | ComprehensiveNetIncome | -15,850,564 |
| 7 | BaseVar | 14,423,465 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.942 |
| 9 | EconomicCapitalRatio | 1.31 |
Edgar->Model Mapping
Feature Distribution
Change over Time
